Humana (NYSE:HUM) Trading Down 0.2%

Shares of Humana Inc. (NYSE:HUM) were down 0.2% during mid-day trading on Monday . The stock traded as low as $303.39 and last traded at $305.31. Approximately 273,967 shares traded hands during trading, a decline of 86% from the average daily volume of 1,973,544 shares. The stock had previously closed at $305.90.

Wall Street Analyst Weigh In

Several brokerages have weighed in on HUM. Jefferies Financial Group dropped their target price on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. UBS Group dropped their target price on Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research report on Thursday. Argus lowered Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Royal Bank of Canada decreased their price target on Humana from $415.00 to $353.00 and set an “outperform” rating for the company in a research note on Thursday. Finally, Raymond James assumed coverage on Humana in a research note on Friday, March 22nd. They issued a “market perform” rating for the company. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $424.50.

Humana Trading Down 0.8 %

The stock has a market cap of $36.57 billion, a P/E ratio of 19.01, a P/E/G ratio of 1.79 and a beta of 0.45. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. The company has a 50-day simple moving average of $327.77 and a 200-day simple moving average of $393.91.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.12 by $1.11. The company had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. Humana’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $9.38 earnings per share. On average, sell-side analysts forecast that Humana Inc. will post 16.08 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.17%. Humana’s payout ratio is 22.04%.

Insider Activity at Humana

In other Humana news, Director Jorge S. Mesquita acquired 545 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the purchase, the director now directly owns 2,578 shares of the company’s stock, valued at $946,358.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.32% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Rakuten Securities Inc. purchased a new stake in Humana in the 4th quarter worth $25,000. Gradient Investments LLC grew its stake in Humana by 200.0% in the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 40 shares in the last quarter. Cetera Trust Company N.A purchased a new stake in shares of Humana in the 4th quarter worth approximately $28,000. Private Wealth Management Group LLC purchased a new stake in Humana during the fourth quarter valued at approximately $32,000. Finally, Nvwm LLC lifted its position in Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after acquiring an additional 25 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.